GleamWall
中文EN

UEEC United Health Products, Inc.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · OTC · SEC CIK 1096938 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY55.4%
TTM EPS YoY100.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-884.9%
ROIC (approx.)—
Asset turnover0.00x

Leverage & solvency

Liabilities / assets2,330.7%
Debt / equity—
Current ratio0.01x
Interest coverage-4.35x

Cash quality & payout

Operating cash flow / net income0.73x
Accruals ratio-235.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$0$0$0$0$0$0$0$0
R&D expense$2,683$3,852$12,562$47,299$36,199$80,983$116,251$108,779
SG&A expense$148,135$162,998$253,019$217,424$207,845$187,373$1.37M$676,619
Operating income-$150,818-$166,850-$265,581-$264,723-$244,044-$268,356-$1.49M-$785,398
Interest expense$59,571$50,456$48,109$36,788$30,684$25,100$20,712$9,483
Net income-$185,268-$284,140-$315,842-$536,908-$296,459-$315,187-$1.54M-$814,112
EBITDA-$149,805-$165,838-$264,568-$263,710-$243,032-$267,344-$1.49M-$784,386
EPS (diluted)0.000.000.00—0.000.00-0.01—
Weighted avg. shares (diluted)262.73M260.04M258.69M—257.81M257.14M254.58M—
Balance sheet
Cash & equivalents$5,588$24,495$1,029$65,249$18,376$225$4,914$168,883
Inventory———————$0
Current assets$27,382$64,664$47,200$105,392$43,129$21,111$35,082$191,683
Intangibles$21,262$22,275$23,287$24,300$25,313$26,325$27,337$28,350
Total assets$204,498$247,985$248,825$316,698$94,313$81,538$104,542$269,979
Current liabilities$4.27M$4.19M$4.19M$4.05M$2.01M$1.90M$1.81M$1.64M
Long-term debt————$927,500$847,500——
Total debt————$927,500$847,500——
Total liabilities$4.77M$4.69M$4.44M$4.30M$3.43M$3.25M$2.96M$2.71M
Shareholders' equity-$4.56M-$4.44M-$4.30M-$3.98M-$3.37M-$3.19M-$2.88M-$2.46M
Net debt————$909,124$847,275——
Shares outstanding263.69M261.59M258.69M258.69M258.69M257.13M257.13M252.41M
Cash flow statement
Operating cash flow-$194,275-$138,013-$84,339-$553,127-$175,157-$184,689-$273,969-$181,438
Investing cash flow$0$0$0$0$0$0$0$0
Financing cash flow$175,368$161,479$20,119$600,000$193,308$180,000$110,000$306,538
Depreciation & amortization$1,013$1,012$1,013$1,013$1,012$1,012$1,013$1,012
Stock-based compensation————$0———

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.